Rezwan Ahmed Mahedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rezwan Ahmed Mahedi has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Sadia Afrin
Department of Pharmacy, Comilla University, Cumilla University
8 shared publications- Mohammad Chand Jamali
College of Medical and Health Sciences, Liwa University, Al Ain, Abu Dhabi, United Arab Emirates
4 shared publications Nikolaos Syrmos
Department of Human Performance and Health, Aristotle University of Thessaloniki, Greece
4 shared publicationsCalvin R. Wei
Department of Research and Development, Shing Huei Group, Taipei, Taiwan
3 shared publicationsMustafa Mudhafar
Department of medical physics, college of applied medical sciences, university of Kerbala, 56001, Karbala Iraq
3 shared publications- Nikolaos Syrmos
School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
3 shared publications
Latest Publications
- Open Access
- 5 March 2026
- Published by Institute of Advanced Engineering and Science in International Journal of Public Health Science (IJPHS)
- Vol. 15 (1) , 197-207
Nipah virus as an emerging threat: mutational dynamics, pathogenesis, and advances in vaccine development- a systematic review
Nipah virus (NiV) is an emerging zoonotic pathogen with significant pandemic potential. Large outbreaks, such as in Malaysia, required the culling of over one million pigs to control transmission. However, the epidemiology of NiV among animal hosts, including pigs, horses, and bats, remains incompletely understood. NiV infection primarily affects the respiratory and nervous systems, causing severe pneumonia, vasculitis, and meningitis, while encephalitis may be mild or infrequent in some cases. This systematic review summarizes current evidence on NiV mutational variation, pathogenesis, treatment strategies, and vaccine development up to 2022. Data were collected from major databases, including PubMed, PMC, and Cochrane Library. Due to limited therapeutic options, NiV management relies mainly on supportive care, as no approved vaccines or specific antiviral treatments are available for humans or livestock. Preventive strategies focus on reducing zoonotic transmission, particularly by minimizing contact between livestock and bat-contaminated food sources, and improving farm management practices. Early detection and continuous surveillance of high-risk populations and animal reservoirs are essential for outbreak control. Current vaccine research targets viral antigens using subunit and vector-based approaches. Overall, further studies are urgently needed to develop effective vaccines and antiviral therapies for NiV infection.
- 5 March 2026
- Published by Institute of Advanced Engineering and Science in International Journal of Public Health Science (IJPHS)
- Vol. 15 (1) , 197-207
Open AccessNipah virus as an emerging threat: mutational dynamics, pathogenesis, and advances in vaccine development- a systematic review
Nipah virus (NiV) is an emerging zoonotic pathogen with significant pandemic potential. Large outbreaks, such as in Malaysia, required the culling of over one million pigs to control transmission. However, the epidemiology of NiV among animal hosts, including pigs, horses, and bats, remains incompletely understood. NiV infection primarily affects the respiratory and nervous systems, causing severe pneumonia, vasculitis, and meningitis, while encephalitis may be mild or infrequent in some cases. This systematic review summarizes current evidence on NiV mutational variation, pathogenesis, treatment strategies, and vaccine development up to 2022. Data were collected from major databases, including PubMed, PMC, and Cochrane Library. Due to limited therapeutic options, NiV management relies mainly on supportive care, as no approved vaccines or specific antiviral treatments are available for humans or livestock. Preventive strategies focus on reducing zoonotic transmission, particularly by minimizing contact between livestock and bat-contaminated food sources, and improving farm management practices. Early detection and continuous surveillance of high-risk populations and animal reservoirs are essential for outbreak control. Current vaccine research targets viral antigens using subunit and vector-based approaches. Overall, further studies are urgently needed to develop effective vaccines and antiviral therapies for NiV infection.
- Open Access
- 1 March 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (4)
Ethnomedicinal Uses, Phytochemical Constituents and Pharmacological Properties of Clerodendrum infortunatum Linn: A Review
Background: Clerodendrum infortunatum L., a member of the Lamiaceae family, is an important ethnopharmacologically relevant plant that is widely used in the traditional management of infectious, inflammatory, metabolic, and parasitic diseases in South and Southeast Asia. Although this plant is widely used in traditional medicine, scientific evidence is still in an unorganized state. Objective: The purpose of this review is to present consolidated information on ethnomedicinal uses, phytoconstituents, and pharmacological properties of Clerodendrum infortunatum. Methods: Appropriate keywords were used in the search for relevant literature from Google Scholar and PubMed databases regarding the phytochemical, ethnomedicinal, and pharmacological effects of Clerodendrum infortunatum . Results: Ethnomedical research shows that stems, roots, leaves, and flowers can be used as treatments for fever, helminthiasis, wound healing, inflammation, respiratory issues, skin problems, and envenomation. In secondary metabolite studies, research found elements such as flavonoids, phenolic acids, clerodane diterpenoids, phenolic acids, steroids, saponins, fatty acids, and nitrogen compounds. Preclinical research, mostly in vitro and in vivo studies, reports evidence of a wide range of biological activities such as inflammation, anti-infection, anti-helminth, liver protection, anti-diabetic, pain relief, anti-epileptic, wound healing, and anticancer activities. Conclusion: The available evidence is mainly preclinical and has little to no mechanistic explanation, varies in extraction procedures, lacks standardization in plant matter, and has underdeveloped toxicity and pharmacokinetic studies. There are no clinical trials in humans, and some parts of plants, especially the fruits and flowers, are still understudied. Clerodendrum infortunatum is an ethnopharmacologically relevant species with some hopeful preclinical data, but the rigorous phytochemical standardisation, mechanistic study, thorough clinical trial design are critical to prove the potential of this plant in evidence-based therapeutics.
- 1 March 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (4)
Open AccessEthnomedicinal Uses, Phytochemical Constituents and Pharmacological Properties of Clerodendrum infortunatum Linn: A Review
Background: Clerodendrum infortunatum L., a member of the Lamiaceae family, is an important ethnopharmacologically relevant plant that is widely used in the traditional management of infectious, inflammatory, metabolic, and parasitic diseases in South and Southeast Asia. Although this plant is widely used in traditional medicine, scientific evidence is still in an unorganized state. Objective: The purpose of this review is to present consolidated information on ethnomedicinal uses, phytoconstituents, and pharmacological properties of Clerodendrum infortunatum. Methods: Appropriate keywords were used in the search for relevant literature from Google Scholar and PubMed databases regarding the phytochemical, ethnomedicinal, and pharmacological effects of Clerodendrum infortunatum . Results: Ethnomedical research shows that stems, roots, leaves, and flowers can be used as treatments for fever, helminthiasis, wound healing, inflammation, respiratory issues, skin problems, and envenomation. In secondary metabolite studies, research found elements such as flavonoids, phenolic acids, clerodane diterpenoids, phenolic acids, steroids, saponins, fatty acids, and nitrogen compounds. Preclinical research, mostly in vitro and in vivo studies, reports evidence of a wide range of biological activities such as inflammation, anti-infection, anti-helminth, liver protection, anti-diabetic, pain relief, anti-epileptic, wound healing, and anticancer activities. Conclusion: The available evidence is mainly preclinical and has little to no mechanistic explanation, varies in extraction procedures, lacks standardization in plant matter, and has underdeveloped toxicity and pharmacokinetic studies. There are no clinical trials in humans, and some parts of plants, especially the fruits and flowers, are still understudied. Clerodendrum infortunatum is an ethnopharmacologically relevant species with some hopeful preclinical data, but the rigorous phytochemical standardisation, mechanistic study, thorough clinical trial design are critical to prove the potential of this plant in evidence-based therapeutics.
- Open Access
- 6 October 2025
- Published by Universa Medicina in Universa Medicina
- Vol. 44 (3)
Bortezomib in multiple myeloma management
Multiple myeloma (MM) is a hematologic malignancy characterized by the uncontrolled proliferation of plasma cells, leading to complications such as bone lesions, renal dysfunction, and immune suppression. Over the past three decades, its incidence has risen significantly, attributed to factors such as aging populations and improved diagnostic methods. Treatment strategies have evolved considerably, transitioning from alkylating agents and high-dose chemotherapy to targeted therapies, including proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs). Bortezomib, a first-in-class PI, has revolutionized MM management by inhibiting proteasome activity, thereby inducing apoptosis in malignant plasma cells. This review evaluates the efficacy, safety, and clinical applications of bortezomib, both as monotherapy and in combination with dexamethasone, IMiDs, and conventional chemotherapies. Key clinical trials, such as VISTA and SUMMIT, demonstrate its superiority over traditional regimens, improving response rates and survival outcomes. However, its use is associated with adverse effects, including peripheral neuropathy, hematologic toxicities, and gastrointestinal disturbances, necessitating dose modifications and supportive care. Emerging combinations with monoclonal antibodies and novel agents further enhance therapeutic potential, though optimal sequencing remains under investigation. Systematic literature search was performed using PubMed and Cochrane to identify relevant studies on the applications of bortezomib. The search was inclusive of all publications up to May 2025, without restriction by publication year, to ensure a thorough review of research on bortezomib. Studies focusing on multiple myeloma (MM) and the efficacy of bortezomib were prioritized. A broad set of keywords was employed reflecting the diverse applications of bortezomib in MM treatment. The search strategy was designed to capture a wide range of relevant studies. By synthesizing evidence from 77 studies, this review highlights bortezomib’s pivotal role in MM treatment while addressing challenges in toxicity management. Future research should focus on refining combination strategies and minimizing side effects to maximize long-term patient outcomes.
- 6 October 2025
- Published by Universa Medicina in Universa Medicina
- Vol. 44 (3)
Open AccessBortezomib in multiple myeloma management
Multiple myeloma (MM) is a hematologic malignancy characterized by the uncontrolled proliferation of plasma cells, leading to complications such as bone lesions, renal dysfunction, and immune suppression. Over the past three decades, its incidence has risen significantly, attributed to factors such as aging populations and improved diagnostic methods. Treatment strategies have evolved considerably, transitioning from alkylating agents and high-dose chemotherapy to targeted therapies, including proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs). Bortezomib, a first-in-class PI, has revolutionized MM management by inhibiting proteasome activity, thereby inducing apoptosis in malignant plasma cells. This review evaluates the efficacy, safety, and clinical applications of bortezomib, both as monotherapy and in combination with dexamethasone, IMiDs, and conventional chemotherapies. Key clinical trials, such as VISTA and SUMMIT, demonstrate its superiority over traditional regimens, improving response rates and survival outcomes. However, its use is associated with adverse effects, including peripheral neuropathy, hematologic toxicities, and gastrointestinal disturbances, necessitating dose modifications and supportive care. Emerging combinations with monoclonal antibodies and novel agents further enhance therapeutic potential, though optimal sequencing remains under investigation. Systematic literature search was performed using PubMed and Cochrane to identify relevant studies on the applications of bortezomib. The search was inclusive of all publications up to May 2025, without restriction by publication year, to ensure a thorough review of research on bortezomib. Studies focusing on multiple myeloma (MM) and the efficacy of bortezomib were prioritized. A broad set of keywords was employed reflecting the diverse applications of bortezomib in MM treatment. The search strategy was designed to capture a wide range of relevant studies. By synthesizing evidence from 77 studies, this review highlights bortezomib’s pivotal role in MM treatment while addressing challenges in toxicity management. Future research should focus on refining combination strategies and minimizing side effects to maximize long-term patient outcomes.
- 1 October 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (10) , 5109-5118
Ethnomedicinal Significance, Phytochemical Profile, and Therapeutic Potentials of Artocarpus chama (Chapalish): A Review
A massive deciduous tree belonging to the Moraceae family, Chapalish (also known as Monkey Jack) is the Artocarpus genus. 'Chamfol' is a common name for this plant in Bangladesh; other names include Artocarpus chaplasha Linn and Artocarpus chama. These trees do best in humid tropical woods, where they may be found among thick stands of evergreen or deciduous trees. March and April flower, while June and August are fruit-ripening months for the globose, tuberculate fruits. Its range extends from Nepal to the east and includes the outlying hills and the Sub-Himalayan area. It may be found in the Andaman Islands, Assam, and Burma at heights of up to 5,000 feet. India, Myalunar, and Arunachal Pradesh is Bangladesh. This tree is most common in the following areas of Bangladesh - Sylhet Division, Chittagong Hill Tracts, Madhupur Forest, Chittagong and Cox's Bazar Hill Forests. For the healing of wounds, it has therapeutic characteristics. On top of that, it possesses antioxidant, anti-inflammatory, and anti-diabetic effects. Constipation and stomach ulcers are two other conditions that it can alleviate. Like jackfruit, it has a wide variety of compounds that make it healthier and more useful medicinally. On top of that, it probably has a lot of vitamins and minerals that are good for your heart and metabolism. Artocarpus chama is evaluated for its botanical description, geographical distribution, and ethnopharmacological properties in this review that gathers research on the plant.
- 1 October 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (10) , 5109-5118
Ethnomedicinal Significance, Phytochemical Profile, and Therapeutic Potentials of Artocarpus chama (Chapalish): A Review
A massive deciduous tree belonging to the Moraceae family, Chapalish (also known as Monkey Jack) is the Artocarpus genus. 'Chamfol' is a common name for this plant in Bangladesh; other names include Artocarpus chaplasha Linn and Artocarpus chama. These trees do best in humid tropical woods, where they may be found among thick stands of evergreen or deciduous trees. March and April flower, while June and August are fruit-ripening months for the globose, tuberculate fruits. Its range extends from Nepal to the east and includes the outlying hills and the Sub-Himalayan area. It may be found in the Andaman Islands, Assam, and Burma at heights of up to 5,000 feet. India, Myalunar, and Arunachal Pradesh is Bangladesh. This tree is most common in the following areas of Bangladesh - Sylhet Division, Chittagong Hill Tracts, Madhupur Forest, Chittagong and Cox's Bazar Hill Forests. For the healing of wounds, it has therapeutic characteristics. On top of that, it possesses antioxidant, anti-inflammatory, and anti-diabetic effects. Constipation and stomach ulcers are two other conditions that it can alleviate. Like jackfruit, it has a wide variety of compounds that make it healthier and more useful medicinally. On top of that, it probably has a lot of vitamins and minerals that are good for your heart and metabolism. Artocarpus chama is evaluated for its botanical description, geographical distribution, and ethnopharmacological properties in this review that gathers research on the plant.
- Open Access
- 7 March 2025
- Published by Scientific Scholar in Future Health
- Vol. 3, 10-17
Symptomatic pattern changes and climatic factors in dengue outbreaks in Bangladesh
Public health in Bangladesh, especially in the last several years, has been greatly affected by dengue fever, caused by a virus spread by mosquitoes. The illness, which was first recorded in Dhaka in 1964, under the name “Dhaka Fever”, has continued to rise in both incidence and fatality rates despite the attempts to control it. With 96,228 cases and 531 fatalities recorded in 2024, Bangladesh is among the top nations for dengue mortality. Environmental changes, unplanned urbanization, and the adaptive behavior of mosquito species Aedes aegypti and Aedes albopictus are the causes of this dramatic increase. Due to increased temperatures and prolonged humidity caused by climate change, the breeding season is now longer than in the typical monsoon months, resulting in outbreaks that happen all year round. Expanded dengue syndrome and other new infection patterns and symptoms make diagnosis and treatment more challenging. The illness is more common in men of working age, yet it kills more women than men. There has been an uptick in cases and deaths in areas outside big cities as well, including Chittagong and Barisal. Identifying worrisome hotspots, controlling mosquito populations, and raising public awareness about unusual dengue symptoms are all necessary to combat this growing epidemic. This research highlights the critical need for implementing comprehensive plans to fight dengue and lessen its social and economic effects in Bangladesh.
- 7 March 2025
- Published by Scientific Scholar in Future Health
- Vol. 3, 10-17
Open AccessSymptomatic pattern changes and climatic factors in dengue outbreaks in Bangladesh
Public health in Bangladesh, especially in the last several years, has been greatly affected by dengue fever, caused by a virus spread by mosquitoes. The illness, which was first recorded in Dhaka in 1964, under the name “Dhaka Fever”, has continued to rise in both incidence and fatality rates despite the attempts to control it. With 96,228 cases and 531 fatalities recorded in 2024, Bangladesh is among the top nations for dengue mortality. Environmental changes, unplanned urbanization, and the adaptive behavior of mosquito species Aedes aegypti and Aedes albopictus are the causes of this dramatic increase. Due to increased temperatures and prolonged humidity caused by climate change, the breeding season is now longer than in the typical monsoon months, resulting in outbreaks that happen all year round. Expanded dengue syndrome and other new infection patterns and symptoms make diagnosis and treatment more challenging. The illness is more common in men of working age, yet it kills more women than men. There has been an uptick in cases and deaths in areas outside big cities as well, including Chittagong and Barisal. Identifying worrisome hotspots, controlling mosquito populations, and raising public awareness about unusual dengue symptoms are all necessary to combat this growing epidemic. This research highlights the critical need for implementing comprehensive plans to fight dengue and lessen its social and economic effects in Bangladesh.
- 27 January 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (1) , 402-408
Exposures to Poisoning to Forensic Investigations and Public Health Views - A Toxicology Tapestry
The study of poisons and their effects includes detection, measurement, toxicity, fatal dose, and therapy. Medical and legal issues related to substance-induced injury are the focus of forensic toxicology. This study discusses poisonings, their consequences, and forensic investigations. Children are especially susceptible to poisoning from suicide attempts, murders, accidents, and unintended exposures. For profit or revenge, homicidal poisoning occurs. The paper describes toxic symptoms and diagnosing difficulties. Toxin-related gastrointestinal, ophthalmic, and cutaneous disorders, symptoms, and vital signs are included in tables. Skin examination is important for determining poisoning pathways because of cutaneous evidence. Visual impairments, ocular indicators, and poisoning symptoms are given to help identify dangerous chemicals. Poison control centres handle poisoning episodes, provide toxicological information, treatment guidance, public health surveillance, professional consultation, toxicovigilance, emergency response, and quality improvement. The report stresses the need of international collaboration in poison control centre establishment and maintenance. Healthcare professionals and the public need poison information sources, such as databases and apps, to manage poisoning incidents. A complete list of materials is provided. The study concludes by assessing poison exposure and poisoning circumstances, noting the many ways poisons may hurt or kill. The sensitivity of youngsters to even little amounts of narcotics is stressed. The research concludes that poisoning diagnosis is complicated due to the many symptoms and possible misdiagnoses. It emphasises evidence-based knowledge and poison control centres and information sources in managing and preventing poisonings.
- 27 January 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 18 (1) , 402-408
Exposures to Poisoning to Forensic Investigations and Public Health Views - A Toxicology Tapestry
The study of poisons and their effects includes detection, measurement, toxicity, fatal dose, and therapy. Medical and legal issues related to substance-induced injury are the focus of forensic toxicology. This study discusses poisonings, their consequences, and forensic investigations. Children are especially susceptible to poisoning from suicide attempts, murders, accidents, and unintended exposures. For profit or revenge, homicidal poisoning occurs. The paper describes toxic symptoms and diagnosing difficulties. Toxin-related gastrointestinal, ophthalmic, and cutaneous disorders, symptoms, and vital signs are included in tables. Skin examination is important for determining poisoning pathways because of cutaneous evidence. Visual impairments, ocular indicators, and poisoning symptoms are given to help identify dangerous chemicals. Poison control centres handle poisoning episodes, provide toxicological information, treatment guidance, public health surveillance, professional consultation, toxicovigilance, emergency response, and quality improvement. The report stresses the need of international collaboration in poison control centre establishment and maintenance. Healthcare professionals and the public need poison information sources, such as databases and apps, to manage poisoning incidents. A complete list of materials is provided. The study concludes by assessing poison exposure and poisoning circumstances, noting the many ways poisons may hurt or kill. The sensitivity of youngsters to even little amounts of narcotics is stressed. The research concludes that poisoning diagnosis is complicated due to the many symptoms and possible misdiagnoses. It emphasises evidence-based knowledge and poison control centres and information sources in managing and preventing poisonings.
- 27 December 2024
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 17 (12) , 6158-6164
A Systematic Review of Bioinformatics' Influence on Drug Developments
Drug development is both a task and a promise for fighting illnesses and improving health. Innovative treatments for cancer, infectious diseases, chronic illnesses, and uncommon genetic abnormalities have long been difficult and resource-intensive to develop. In the 21st century, bioinformatics has become a pioneering and essential technique for drug development. Bioinformatics uses computational algorithms, statistical analysis, and data-driven insights to understand life's core biological processes. Bioinformatics helps drug discovery researchers understand illness biological mechanisms, identify therapeutic targets, screen candidate molecules, and improve drug development pipelines. Drug development has been defined by fortuitous discoveries and tedious laboratory work, requiring years or decades to get a possible therapeutic agent to the patient bedside. Bioinformatics has transformed drug development in biomedicine today. This comprehensive study examines how bioinformatics has changed medication development. We want to study and analyse bioinformatics' many uses. We discover the complex network of genomes, proteomics, structural biology, and computational modelling that underscores bioinformatics' vital significance as we investigate this dynamic subject. This review illuminates the difficult balance between biological knowledge and computational capabilities to produce innovative treatments. The systematic review uses a thorough literature search, study selection criteria, and data extraction. Genomic target identification, virtual screening, pharmacophore modelling, pathway analysis, and toxicity prediction are among the bioinformatics applications in drug development we find and classify. These examples demonstrate bioinformatics' ability to accelerate medication development. The systematic review covers bioinformatics' drug discovery applications and shows how this diverse discipline is changing pharmaceutical research. It shows how to improve medication development, reduce side effects, and achieve precision medicine. The combination of bioinformatics and drug development offers optimism for easing human suffering, extending lifespans, and fighting a broad range of illnesses.
- 27 December 2024
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 17 (12) , 6158-6164
A Systematic Review of Bioinformatics' Influence on Drug Developments
Drug development is both a task and a promise for fighting illnesses and improving health. Innovative treatments for cancer, infectious diseases, chronic illnesses, and uncommon genetic abnormalities have long been difficult and resource-intensive to develop. In the 21st century, bioinformatics has become a pioneering and essential technique for drug development. Bioinformatics uses computational algorithms, statistical analysis, and data-driven insights to understand life's core biological processes. Bioinformatics helps drug discovery researchers understand illness biological mechanisms, identify therapeutic targets, screen candidate molecules, and improve drug development pipelines. Drug development has been defined by fortuitous discoveries and tedious laboratory work, requiring years or decades to get a possible therapeutic agent to the patient bedside. Bioinformatics has transformed drug development in biomedicine today. This comprehensive study examines how bioinformatics has changed medication development. We want to study and analyse bioinformatics' many uses. We discover the complex network of genomes, proteomics, structural biology, and computational modelling that underscores bioinformatics' vital significance as we investigate this dynamic subject. This review illuminates the difficult balance between biological knowledge and computational capabilities to produce innovative treatments. The systematic review uses a thorough literature search, study selection criteria, and data extraction. Genomic target identification, virtual screening, pharmacophore modelling, pathway analysis, and toxicity prediction are among the bioinformatics applications in drug development we find and classify. These examples demonstrate bioinformatics' ability to accelerate medication development. The systematic review covers bioinformatics' drug discovery applications and shows how this diverse discipline is changing pharmaceutical research. It shows how to improve medication development, reduce side effects, and achieve precision medicine. The combination of bioinformatics and drug development offers optimism for easing human suffering, extending lifespans, and fighting a broad range of illnesses.
- Open Access
- 12 October 2024
- Published by Health, Utan Kayu Publishing in Journal of Current Health Sciences
- Vol. 4 (2) , 95-104
Current Trends and Future Prospects of Artificial Intelligence in Transforming Radiology
Artificial intelligence (AI) has rapidly transformed numerous industries, including medicine, with radiography standing to benefit significantly from its capabilities. AI enhances diagnostic accuracy, reduces errors, and improves patient care by leveraging large datasets from digital radiographs commonly used in medical and dental practices. Despite these advantages, the impact of AI on image acquisition and radiographer workflows remains underexplored in radiography literature. This review aims to evaluate the effects of AI on radiographic practices, address regulatory challenges, and explore its integration into educational frameworks for radiologists and radiographers. It highlights AI's role in automating tasks, enhancing diagnostic precision, and improving clinical decision-making. A systematic literature search was conducted using PubMed and Google Scholar up to December 2024, with terms including "artificial intelligence," "machine learning," "deep learning," "radiography," and "diagnostic imaging." Seventy-seven peer-reviewed articles and conference papers focusing on AI applications in digital dental radiography were analyzed to extract data on AI methodologies and their potential applications. The findings reveal that AI-powered solutions enhance efficiency in complex imaging tasks, such as lesion identification and triage in mammography, and real-time assessments in cross-sectional imaging, reducing the need for re-scans and increasing patient throughput. However, widespread adoption faces obstacles related to ethical and legal concerns, including data privacy, algorithmic bias, and the need for transparency. While AI demonstrates significant potential to automate workflows, improve diagnostic accuracy, and optimize patient care in radiography, challenges related to human oversight, professional adaptation, and regulatory compliance must be addressed. Further research is needed to fully understand AI’s impact on radiography and to maximize its clinical utility.
- 12 October 2024
- Published by Health, Utan Kayu Publishing in Journal of Current Health Sciences
- Vol. 4 (2) , 95-104
Open AccessCurrent Trends and Future Prospects of Artificial Intelligence in Transforming Radiology
Artificial intelligence (AI) has rapidly transformed numerous industries, including medicine, with radiography standing to benefit significantly from its capabilities. AI enhances diagnostic accuracy, reduces errors, and improves patient care by leveraging large datasets from digital radiographs commonly used in medical and dental practices. Despite these advantages, the impact of AI on image acquisition and radiographer workflows remains underexplored in radiography literature. This review aims to evaluate the effects of AI on radiographic practices, address regulatory challenges, and explore its integration into educational frameworks for radiologists and radiographers. It highlights AI's role in automating tasks, enhancing diagnostic precision, and improving clinical decision-making. A systematic literature search was conducted using PubMed and Google Scholar up to December 2024, with terms including "artificial intelligence," "machine learning," "deep learning," "radiography," and "diagnostic imaging." Seventy-seven peer-reviewed articles and conference papers focusing on AI applications in digital dental radiography were analyzed to extract data on AI methodologies and their potential applications. The findings reveal that AI-powered solutions enhance efficiency in complex imaging tasks, such as lesion identification and triage in mammography, and real-time assessments in cross-sectional imaging, reducing the need for re-scans and increasing patient throughput. However, widespread adoption faces obstacles related to ethical and legal concerns, including data privacy, algorithmic bias, and the need for transparency. While AI demonstrates significant potential to automate workflows, improve diagnostic accuracy, and optimize patient care in radiography, challenges related to human oversight, professional adaptation, and regulatory compliance must be addressed. Further research is needed to fully understand AI’s impact on radiography and to maximize its clinical utility.
- Open Access
- 30 June 2024
- Published by Science Alert in Asian Science Bulletin
- Vol. 2 (2) , 112-122
Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS)
Post-acute COVID-19 syndrome, often known as “long COVID,” results from the global COVID-19 pandemic and is defined by the persistence of clinical symptoms long after the original infection has faded. In this study, the complex connection between mental health and gastrointestinal function in the setting of post-acute COVID-19 syndrome was explored. The study, based on clinical data and evaluations of the relevant literature, highlights the enormous effect of neurological and neuropsychiatric disorders on patients’ lives. Not only do many symptoms like weariness, cognitive impairment and sleep difficulties persist long after the acute phase of the disease has gone, but they tend to worsen with time. The research also examines the incidence of depression after COVID-19 infection, looking at potential risk variables such as age, gender and inflammatory status. Individuals recuperating from COVID-19 experience heightened sensitivity to psychological distress owing to variables including isolation, financial instability and delayed schooling, highlighting the epidemic’s more considerable social and economic repercussions. This investigation also sheds insight into the function of systemic inflammation and microbiota dysbiosis in post-acute COVID-19 syndrome and the intricate relationship between the gut and the brain. The study highlights the critical need for a multifaceted strategy for addressing this illness, calling for coordinated medical, psychological and social therapies. Essential components of a comprehensive plan to address the various issues faced by post-acute COVID-19 syndrome include access to healthcare services, mental health support, financial aid and possibilities for social reintegration. To improve the quality of life for people dealing with the fallout of this unprecedented global health crisis, a deeper understanding of the interplay between psychological and social factors and gastrointestinal health is required. APA-7 Style Mahedi, M.R., Shahidul Islam, S.M., Jamali, M., Wei, C.R., Afrin, S., Syrmos, N. (2024). Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS). Asian Science Bulletin, 2(2), 112-122. https://doi.org/10.3923/asb.2024.112.122 ACS Style Mahedi, M.R.; Shahidul Islam, S.M.; Jamali, M.; Wei, C.R.; Afrin, S.; Syrmos, N. Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS). Asian Sci. Bul 2024, 2, 112-122. https://doi.org/10.3923/asb.2024.112.122 AMA Style Mahedi MR, Shahidul Islam SM, Jamali M, Wei CR, Afrin S, Syrmos N. Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS). Asian Science Bulletin. 2024; 2(2): 112-122. https://doi.org/10.3923/asb.2024.112.122 Chicago/Turabian Style Mahedi, Md., Rezwan Ahmed, Syed Mahmood Shahidul Islam, Mohammad Jamali, Calvin Ronchen Wei, Sadia Afrin, and Nikolaos Syrmos. 2024. "Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS)" Asian Science Bulletin 2, no. 2: 112-122. https://doi.org/10.3923/asb.2024.112.122
- 30 June 2024
- Published by Science Alert in Asian Science Bulletin
- Vol. 2 (2) , 112-122
Open AccessNeurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS)
Post-acute COVID-19 syndrome, often known as “long COVID,” results from the global COVID-19 pandemic and is defined by the persistence of clinical symptoms long after the original infection has faded. In this study, the complex connection between mental health and gastrointestinal function in the setting of post-acute COVID-19 syndrome was explored. The study, based on clinical data and evaluations of the relevant literature, highlights the enormous effect of neurological and neuropsychiatric disorders on patients’ lives. Not only do many symptoms like weariness, cognitive impairment and sleep difficulties persist long after the acute phase of the disease has gone, but they tend to worsen with time. The research also examines the incidence of depression after COVID-19 infection, looking at potential risk variables such as age, gender and inflammatory status. Individuals recuperating from COVID-19 experience heightened sensitivity to psychological distress owing to variables including isolation, financial instability and delayed schooling, highlighting the epidemic’s more considerable social and economic repercussions. This investigation also sheds insight into the function of systemic inflammation and microbiota dysbiosis in post-acute COVID-19 syndrome and the intricate relationship between the gut and the brain. The study highlights the critical need for a multifaceted strategy for addressing this illness, calling for coordinated medical, psychological and social therapies. Essential components of a comprehensive plan to address the various issues faced by post-acute COVID-19 syndrome include access to healthcare services, mental health support, financial aid and possibilities for social reintegration. To improve the quality of life for people dealing with the fallout of this unprecedented global health crisis, a deeper understanding of the interplay between psychological and social factors and gastrointestinal health is required. APA-7 Style Mahedi, M.R., Shahidul Islam, S.M., Jamali, M., Wei, C.R., Afrin, S., Syrmos, N. (2024). Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS). Asian Science Bulletin, 2(2), 112-122. https://doi.org/10.3923/asb.2024.112.122 ACS Style Mahedi, M.R.; Shahidul Islam, S.M.; Jamali, M.; Wei, C.R.; Afrin, S.; Syrmos, N. Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS). Asian Sci. Bul 2024, 2, 112-122. https://doi.org/10.3923/asb.2024.112.122 AMA Style Mahedi MR, Shahidul Islam SM, Jamali M, Wei CR, Afrin S, Syrmos N. Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS). Asian Science Bulletin. 2024; 2(2): 112-122. https://doi.org/10.3923/asb.2024.112.122 Chicago/Turabian Style Mahedi, Md., Rezwan Ahmed, Syed Mahmood Shahidul Islam, Mohammad Jamali, Calvin Ronchen Wei, Sadia Afrin, and Nikolaos Syrmos. 2024. "Neurological Factors and Gastrointestinal Health in Post-Acute COVID-19 Syndrome (PACS)" Asian Science Bulletin 2, no. 2: 112-122. https://doi.org/10.3923/asb.2024.112.122
- 22 April 2024
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 17 (4) , 1902-1908
Examining the Interplay of Psychological Factors in Chronic Skin Disease: A Review on Depression, Anxiety, and Stress
The genesis of chronic skin illnesses is intricately intertwined with genetics, the environment, psychological and the immune system. However, recent studies have shown that mental health issues can exacerbate and control the severity of chronic skin disorders. Focusing on illnesses including psoriasis, atopic dermatitis, and urticaria, this article seeks to evaluate and discuss the current literature on the interplay of psychological aspects in chronic skin diseases. Here, we investigate the two-way connection between emotional discomfort (such as stress, worry, or depression) and the physiology of various skin conditions. Furthermore, we address possible mechanisms underlying the link between mental health and skin diseases, which will help the physicians to select the medicines and treatment approach.
- 22 April 2024
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 17 (4) , 1902-1908
Examining the Interplay of Psychological Factors in Chronic Skin Disease: A Review on Depression, Anxiety, and Stress
The genesis of chronic skin illnesses is intricately intertwined with genetics, the environment, psychological and the immune system. However, recent studies have shown that mental health issues can exacerbate and control the severity of chronic skin disorders. Focusing on illnesses including psoriasis, atopic dermatitis, and urticaria, this article seeks to evaluate and discuss the current literature on the interplay of psychological aspects in chronic skin diseases. Here, we investigate the two-way connection between emotional discomfort (such as stress, worry, or depression) and the physiology of various skin conditions. Furthermore, we address possible mechanisms underlying the link between mental health and skin diseases, which will help the physicians to select the medicines and treatment approach.